Claims
- 1. A method for the treatment of disorders responsive to opening of the KCNQ potassium channels in a mammal in need thereof, which comprises administering to said mammal a therapeutically effective amount of a compound of Formula I
- 2. The method of claim 1 wherein the compound of Formula I is selected from a compound having the structure
- 3. The method of claim 1 wherein said disorder is migraine or migraine-like attack.
- 4. The method of claim 2 wherein said disorder is migraine or migraine-like attack.
- 5. A pharmaceutical composition for the treatment of disorders responsive to opening of KCNQ potassium channels comprising a therapeutically effective amount of the compound of claim 1 in association with a pharmaceutically acceptable carrier, adjuvant or diluent.
- 6. A pharmaceutical composition for the treatment of disorders responsive to opening of KCNQ potassium channels comprising a therapeutically effective amount of the compound of claim 2 in association with a pharmaceutically acceptable carrier, adjuvant or diluent.
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This is a non-provisional application which claims the benefit of U.S. Provisional Application No. 60/269,800 filed Feb. 20, 2001.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60269800 |
Feb 2001 |
US |